Evidence map›Paper›PMID 42422837›Full record

ArticleFrontiers in medicine2026

Inflammatory phenotypes in acute respiratory distress syndrome: external validation and model simplification in multicenter cohorts.

Yuanyuan Li, Wenqiang Li, Feng Qu, Ping Wei

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuanyuan LiDepartment of ICU, Jining No.1 People's Hospital, Jining, Shandong, China.
Wenqiang LiDepartment of ICU, Jining No.1 People's Hospital, Jining, Shandong, China.
Feng QuDepartment of ICU, Jining No.1 People's Hospital, Jining, Shandong, China.
Ping WeiSchool of Public Health, Shandong Second Medical University, Weifang, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammatory phenotyping represents a promising approach for risk stratification in acute respiratory distress syndrome (ARDS). A previously developed 18-variable model classifies patients into hyperinflammatory and hypoinflammatory phenotypes; however, its generalizability and feasibility for routine implementation remain uncertain. We aimed to externally validate this model and determine whether a simplified 17-variable version, excluding minute ventilation, maintains equivalent prognostic performance. Methods: This retrospective cohort study was conducted using the Medical Information Market for Intensive Care IV (MIMIC-IV) and electronic intensive care unit (eICU) Collaborative Research Database. In the MIMIC-IV cohort, inflammatory phenotypes were assigned using the original 18-variable model, and their association with 30-day mortality was evaluated using logistic regression. A simplified 17-variable model excluding minute ventilation was also assessed. Model discrimination was compared using the area under the receiver operating characteristic curve (AUC) and DeLong's test. External validation was performed in the eICU cohort. Sensitivity analyses included multiple imputation in MIMIC-IV and complete-case analysis in the eICU cohort. Results: In the MIMIC-IV cohort ( Conclusion: The inflammatory phenotype model demonstrated robust prognostic value across independent ARDS cohorts. A simplified 17-variable model, excluding minute ventilation, maintained an equivalent performance, supporting its potential as a practical and generalizable tool for clinical implementation.

Indexed as

acute respiratory distress syndromeexternal validationinflammatory phenotypeprognosisrisk stratification

Identifiers

PMID42422837
PMCPMC13342228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.